📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes. (2020)

First Author: Ai Ng SY

Attributed to: Adiposity and kidney disease: observations from large blood-based prospective cohorts across a wide range of different populations funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7326/acpj202002180-018

PubMed Identifier: 32066151

Publication URI: http://europepmc.org/abstract/MED/32066151

Type: Journal Article/Review

Volume: 172

Parent Publication: Annals of internal medicine

Issue: 4

ISSN: 0003-4819